Bill would rein in “pharmacy benefit managers,” or PBMs, which have come under fire for driving up prescription drug costs ...

The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...

Only nine of 25 states with an approved Medicaid SPA for an innovative payment arrangement addressing novel and expensive ...

WHY ARE COSTS DIFFERENT FOR BRAND-NAME DRUGS VS ... The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or ...

Health care can be expensive even with Medicare. Here are three tips to ensure you're getting the most affordable care, ...

Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...

Several bills this session deal with a federal program known as the 340B Drug Pricing Program. Lawmakers say the measures ...

WHY ARE COSTS DIFFERENT FOR BRAND-NAME DRUGS VS ... The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or ...

Tiffany Meng, PharmD, oncology pharmacist, UCSF Health, discusses ways that pharmacists can help guide patients to financial ...

other drugmakers can create generic versions. This competition in the market can lead to lower costs for generics. And because generics have the same active ingredients as brand-name drugs ...

Meanwhile, average expected out-of-pocket costs in standalone Part D plans also increased substantially for other common preferred branded drugs. Like Eliquis, some saw increases of more than ...

“The real stroke of brilliance is the notion that you make the cell younger, and then it would be more resilient to injury,” ...